Myxoid/round cell and pleomorphic liposarcomas: Prognostic factors and survival in a series of patients treated at a single institution

Cancer

Volumn 109, Issue 12, 2007, Pages 2522-2531

  Fiore, Marco ^a   Grosso, Federica ^a   Lo Vullo, Salvatore ^a   Pennacchioli, Elisabetta ^a   Stacchiotti, Silvia ^a   Ferrari, Andrea ^a   Collini, Paola ^a   Lozza, Laura ^a   Mariani, Luigi ^a   Casali, Paolo G ^a   Gronchi, Alessandro ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Myxoid liposarcoma; Prognosis; Round cell liposarcoma; Sarcoma; Surgery; Survival

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; HUMAN; INCIDENCE; ITALY; LIPOSARCOMA; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MYXOSARCOMA; PLEOMORPHIC LIPOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; ROUND CELL LIPOSARCOMA; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ITALY; LIPOSARCOMA; LIPOSARCOMA, MYXOID; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 34250178427     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22720     Document Type: Article

References (28)

1. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumours. 4th ed. St. Louis, Mo: Mosby, 2001:641-693.
2. Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol. 1996;20:171-180.
3. Knight JC, Renwick PJ, Clin PD, et al. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24-27.
4. Mentzel T, Pedentour F. Pleomorphic liposarcoma. In: Fletcher CDM, Krishan Unni K, Mertens F, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon: International Agency for Research on Cancer Press; 2002:44-45.
5. Meis-Kindblom IM, Sjogren H, Kindblom LG, et al. Cytogenetic and molecular genetic analysis of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis. Virchows Arch. 2001;439:141-151.
6. De Cecco L, Gariboldi M, Reid JF, et al. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS-CHOP transcript. Histopathology. 2005;46:334-341.
7. Pitson G, Robinson R Wilke D, et al. Radiation response: an additional unique signature of myxoid liposarcoma. Int J Radiat Oncol Biol Phys. 2004;60:522-526.
8. Jones RL, Fisher C, Al Muderis O, et al. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer. 2005;41:2853-2860.
9. Grosso F, Demetri GD, Blay JY, et al. Patterns of tumor response to trabectedin (ET743) in myxoid liposarcomas. 2006 ASCO Annual Meeting Proceedings. J Clin Oncol. 2006;24(suppl 18):18S. Abstract 9511.
10. Trojani M, Contesso G, Coindre JM, et al. Soft tissue sarcomas of adults: study of pathological prognostic variables and definition of a histopathologic grading system. Int J Cancer. 1984;33:37-42.
11. Marubini E, Valsecchi MG. Analysing Survival Data for Clinical Trials and Observational Studies. Chichester: John Wiley & Sons; 1995.
12. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1988;16:1141-1154.
13. Kilpatrick SE, Doyon I, Choong PF, et al. The clinicopathologic spectrum of myxoid and round cell liposarcoma: a study of 95 cases. Cancer. 1996;77:1450-1458.
14. Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7:3977-3987.
15. ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ. Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up. Ann Surg Oncol. 2006;14:222-229.
16. Moore Dalai K, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
17. Enneking WP, Spainer SS, Goodman MA. A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop. 1980;153:106-120.
18. Trovik CS, Bauer HCF, Alvegard TA, et al. Surgical margins, local recurrence and metastasis in soft tissue sarcomas: 559 surgically-treated patients from the Scandinavian Sarcoma Group Register. Eur J Cancer. 2000;36:710-716.
19. Stojadinovic A, Leung DHY, Hoos A, et al. Analysis of the prognostic significance of microscopic margins in 2084 localized primary adult soft tissue sarcomas. Ann Surg. 2002;235:424-433.
20. Zagars GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft tissue sarcoma treated with conservation surgery and radiation therapy. An analysis of 1225 patients. Cancer. 2003;97:2530-2543.
21. Gronchi A, Casali PG, Mariani L, et al. Status of surgical margins and prognosis in adult soft tissue sarcomas of the extremities: a series of patients treated at a single institution. J Clin Oncol. 2005;1:96-104.
22. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft tissue sarcoma. Ann Surg. 1995;221:185-195.
23. Gronchi A, Casali GP, Fiore M, et al. Retroperitoneal soft tissue sarcoma: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2455.
24. Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implication for staging and follow-up. Cancer. 1999;85:85-92.
25. Estourgie SH, Nielsen GP, Ott MJ. Metastatic patterns of extremity myxoid liposarcoma and their outcome. J Surg Oncol. 2002;80:89-93.
26. Kattan MW, Leung DHY, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796.
27. Eilber FC, Brennan MF, Eilber FR, et al. Validation of the postoperative nomogram for 12-year sarcoma-specific mortality. Cancer. 2004;101:2270-2275.
28. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer. 2005;103:402-408.